27590630|t|A pH - Sensitive Nanocarrier for Tumor Targeting: Delivery of Ruthenium Complex for Tumor Theranostic by pH - Sensitive Nanocapsule
27590630|a|Ruthenium complex is a potentially theranostic agent for cancer imaging and therapy, however its application is limited due to poor water-solubility and lack of tumor selectivity. To overcome the above drawbacks, pH - sensitive nanocapsule as a novel targeting carrier was designed to deliver ruthenium complex for treating xenograft tumor of mice. The core / shell structured nanocapsule with ruthenium complex tris(1,10-phenanthroline) ruthenium(II) complex (3P-Ru) as the core and a pH - sensitive polymeric material poly (2-diisopropylaminoethyl methacrylate)-block poly(2-aminoethyl methacrylate hydrochloride) (PbPS) as the shell was synthesized and characterized. Meanwhile, the nanocapsule was used to investigate cell viability and evaluate tissue distribution as well as preventing tumor growth efficacy in U251 stem cells tumor -bearing mouse model. The nanocapsule had a size of 103.1 ± 11.3 nm, zeta potential of -40 ± 5.3 mV, EE of 76.7 ± 0.9%, LE of 25.4 ± 0.6% and it could control drug release under different pH conditions. The results of cell uptake showed that the fluorescent 3P-Ru loaded in the nanocapsule could be delivered into cells with high efficiency, and then significantly inhibited U251 proliferation in a concentration - dependent manner. After U251 stem cells were transplanted subcutaneously into mice, the 3P-Ru / PbPS nanocapsule (PbPS - Ru - NC) via intravenous administration could concentrate in tumor area and obviously prevent tumor growth. The pH - sensitive nanocapsule as a antitumor agent carrier was able to effectively deliver 3P-Ru into gliomas cells, and cell growth was significantly inhibited both in vitro and in vivo. Such pH - sensitive nanocapsule for ruthenium complex delivery would have great potential application in tumor theranostics.
27590630	2	4	pH	T081	C0020283
27590630	7	16	Sensitive	T169	C0332324
27590630	17	28	Nanocarrier	T122	C0013161
27590630	33	38	Tumor	T191	C0027651
27590630	39	48	Targeting	T043	C0599894
27590630	50	58	Delivery	T169	C1705822
27590630	62	79	Ruthenium Complex	T197	C0206450
27590630	84	89	Tumor	T191	C0027651
27590630	90	101	Theranostic	T091	C4042913
27590630	105	107	pH	T081	C0020283
27590630	110	119	Sensitive	T169	C0332324
27590630	120	131	Nanocapsule	T073	C1721062
27590630	132	149	Ruthenium complex	T197	C0206450
27590630	167	184	theranostic agent	T121	C1254351
27590630	189	203	cancer imaging	T060	C1655037
27590630	208	215	therapy	T061	C0920425
27590630	264	280	water-solubility	T081	C0597682
27590630	293	298	tumor	T191	C0027651
27590630	299	310	selectivity	T169	C0332324
27590630	315	323	overcome	T052	C2983310
27590630	345	347	pH	T081	C0020283
27590630	350	359	sensitive	T169	C0332324
27590630	360	371	nanocapsule	T073	C1721062
27590630	383	400	targeting carrier	T122	C0013161
27590630	425	442	ruthenium complex	T197	C0206450
27590630	447	455	treating	T169	C1522326
27590630	456	471	xenograft tumor	T191	C0027651
27590630	475	479	mice	T015	C0025929
27590630	485	489	core	T082	C0444669
27590630	492	497	shell	T082	C1254362
27590630	498	508	structured	T082	C0678594
27590630	509	520	nanocapsule	T073	C1721062
27590630	526	543	ruthenium complex	T197	C0206450
27590630	544	591	tris(1,10-phenanthroline) ruthenium(II) complex	T109	C0284795
27590630	593	598	3P-Ru	T109	C0284795
27590630	607	611	core	T082	C0444669
27590630	618	620	pH	T081	C0020283
27590630	623	632	sensitive	T169	C0332324
27590630	633	651	polymeric material	T104,T122	C0032521
27590630	652	747	poly (2-diisopropylaminoethyl methacrylate)-block poly(2-aminoethyl methacrylate hydrochloride)	T104,T122	C0032521
27590630	749	753	PbPS	T104,T122	C0032521
27590630	762	767	shell	T082	C1254362
27590630	772	783	synthesized	T052	C1883254
27590630	788	801	characterized	T052	C1880022
27590630	818	829	nanocapsule	T073	C1721062
27590630	842	853	investigate	T169	C1292732
27590630	854	868	cell viability	T043	C0007620
27590630	873	881	evaluate	T169	C1292732
27590630	882	901	tissue distribution	T169	C0220927
27590630	913	923	preventing	T169	C1292733
27590630	924	936	tumor growth	T191	C0598934
27590630	937	945	efficacy	T080	C1280519
27590630	949	970	U251 stem cells tumor	T025	C1956421
27590630	980	991	mouse model	T050	C2986594
27590630	997	1008	nanocapsule	T073	C1721062
27590630	1015	1019	size	T081	C0030608
27590630	1040	1054	zeta potential	T067	C0597697
27590630	1072	1074	EE	T081	C0392762
27590630	1091	1093	LE	T081	C0392762
27590630	1122	1129	control	T169	C2587213
27590630	1130	1142	drug release	T070	C3850077
27590630	1149	1158	different	T080	C1705242
27590630	1159	1161	pH	T081	C0020283
27590630	1162	1172	conditions	T080	C0348080
27590630	1178	1185	results	T169	C1274040
27590630	1189	1193	cell	T025	C0007634
27590630	1194	1200	uptake	T043	C3888108
27590630	1217	1234	fluorescent 3P-Ru	T109	C0284795
27590630	1249	1260	nanocapsule	T073	C1721062
27590630	1285	1290	cells	T025	C0007634
27590630	1301	1311	efficiency	T081	C0013682
27590630	1336	1345	inhibited	T080	C0311403
27590630	1346	1350	U251	T025	C1956421
27590630	1351	1364	proliferation	T043	C0596290
27590630	1370	1383	concentration	T081	C1446561
27590630	1386	1395	dependent	T080	C0851827
27590630	1410	1425	U251 stem cells	T025	C1956421
27590630	1431	1443	transplanted	T169	C0700106
27590630	1464	1468	mice	T015	C0025929
27590630	1474	1479	3P-Ru	T109	C0284795
27590630	1482	1486	PbPS	T104,T122	C0032521
27590630	1487	1498	nanocapsule	T073	C1721062
27590630	1500	1504	PbPS	T104,T122	C0032521
27590630	1507	1509	Ru	T197	C0206450
27590630	1512	1514	NC	T073	C1721062
27590630	1520	1546	intravenous administration	T082	C0013125
27590630	1553	1564	concentrate	T052	C2003864
27590630	1568	1573	tumor	T191	C0027651
27590630	1574	1578	area	T082	C0205146
27590630	1601	1613	tumor growth	T191	C0598934
27590630	1619	1621	pH	T081	C0020283
27590630	1624	1633	sensitive	T169	C0332324
27590630	1634	1645	nanocapsule	T073	C1721062
27590630	1651	1666	antitumor agent	T109,T121	C0003392
27590630	1707	1712	3P-Ru	T109	C0284795
27590630	1718	1725	gliomas	T191	C0017638
27590630	1726	1731	cells	T025	C0007634
27590630	1737	1748	cell growth	T043	C0007595
27590630	1753	1766	significantly	T078	C0750502
27590630	1767	1776	inhibited	T080	C0311403
27590630	1782	1790	in vitro	T080	C1533691
27590630	1795	1802	in vivo	T082	C1515655
27590630	1809	1811	pH	T081	C0020283
27590630	1814	1823	sensitive	T169	C0332324
27590630	1824	1835	nanocapsule	T073	C1721062
27590630	1840	1857	ruthenium complex	T197	C0206450
27590630	1858	1866	delivery	T169	C1705822
27590630	1909	1914	tumor	T191	C0027651
27590630	1915	1927	theranostics	T091	C4042913